Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives
- Autores
- Slafer, Brian W.; Dessoy, Marco A.; de Oliveira, Ramon G.; Mollo, María Cruz; Lee, Eun; Matheeussen, An; Maes, Louis; Caljon, Guy; Ferreira, Leonardo L. G.; Krogh, Renata; Andricopulo, Adriano D.; Cruz, Luiza R.; Mowbray, Charles E.; Kratz, Jadel M.; Dias, Luiz C.
- Año de publicación
- 2024
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Chagas disease (CD) is a parasitic neglected tropical disease (NTD) caused by the protozoan Trypanosoma cruzi that affects 6 million people worldwide, often resulting in financial burden, morbidity, and mortality in endemic regions. Given a lack of highly efficient and safe treatments, new, affordable, and fit-for-purpose drugs for CD are urgently needed. In this work, we present a hit-to-lead campaign for novel cyanopyridine analogues as antichagasic agents. In a phenotypic screening against intracellular T. cruzi, hits 1 and 2 were identified and displayed promising potency combined with balanced physicochemical properties. As part of the Lead Optimization Latin America consortium, a set of 40 compounds was designed, synthesized, and tested against T. cruzi intracellular amastigotes and relevant human cell lines. The structural modifications were focused on three positions: cyanopyridine core, linker, and right-hand side. The ADME properties of selected compounds, lipophilicity, kinetic solubility, permeability, and liver microsomal stability, were evaluated. Compounds 1–9 displayed good potency (EC50 T. cruzi amastigote <1 μM), and most compounds did not present significant cytotoxicity (CC50 MRC-5 = 32–64 μM). Despite the good balance between potency and selectivity, the antiparasitic activity of the series appeared to be driven by lipophilicity, making the progression of the series unfeasible due to poor ADME properties and potential promiscuity issues.
Fil: Slafer, Brian W.. Universidade Estadual de Campinas; Brasil
Fil: Dessoy, Marco A.. Universidade Estadual de Campinas; Brasil
Fil: de Oliveira, Ramon G.. Universidade Estadual de Campinas; Brasil
Fil: Mollo, María Cruz. Universidade Estadual de Campinas; Brasil. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Lee, Eun. Universidade Estadual de Campinas; Brasil
Fil: Matheeussen, An. Universidade Estadual de Campinas; Brasil
Fil: Maes, Louis. Universidade Estadual de Campinas; Brasil
Fil: Caljon, Guy. Universiteit Antwerp; Bélgica
Fil: Ferreira, Leonardo L. G.. Universidade de Sao Paulo; Brasil
Fil: Krogh, Renata. Universidade de Sao Paulo; Brasil
Fil: Andricopulo, Adriano D.. Universidade de Sao Paulo; Brasil
Fil: Cruz, Luiza R.. No especifíca;
Fil: Mowbray, Charles E.. No especifíca;
Fil: Kratz, Jadel M.. No especifíca;
Fil: Dias, Luiz C.. Universidade Estadual de Campinas; Brasil - Materia
-
TRYPANOSOMA CRUZI
DRUG DISCOVERY
CHAGAS
MULTIPARAMETRIC OPTIMIZATION - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/236058
Ver los metadatos del registro completo
id |
CONICETDig_b2fe30def7ee7c07a5a9cdfb9c0e73df |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/236058 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine DerivativesSlafer, Brian W.Dessoy, Marco A.de Oliveira, Ramon G.Mollo, María CruzLee, EunMatheeussen, AnMaes, LouisCaljon, GuyFerreira, Leonardo L. G.Krogh, RenataAndricopulo, Adriano D.Cruz, Luiza R.Mowbray, Charles E.Kratz, Jadel M.Dias, Luiz C.TRYPANOSOMA CRUZIDRUG DISCOVERYCHAGASMULTIPARAMETRIC OPTIMIZATIONhttps://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1Chagas disease (CD) is a parasitic neglected tropical disease (NTD) caused by the protozoan Trypanosoma cruzi that affects 6 million people worldwide, often resulting in financial burden, morbidity, and mortality in endemic regions. Given a lack of highly efficient and safe treatments, new, affordable, and fit-for-purpose drugs for CD are urgently needed. In this work, we present a hit-to-lead campaign for novel cyanopyridine analogues as antichagasic agents. In a phenotypic screening against intracellular T. cruzi, hits 1 and 2 were identified and displayed promising potency combined with balanced physicochemical properties. As part of the Lead Optimization Latin America consortium, a set of 40 compounds was designed, synthesized, and tested against T. cruzi intracellular amastigotes and relevant human cell lines. The structural modifications were focused on three positions: cyanopyridine core, linker, and right-hand side. The ADME properties of selected compounds, lipophilicity, kinetic solubility, permeability, and liver microsomal stability, were evaluated. Compounds 1–9 displayed good potency (EC50 T. cruzi amastigote <1 μM), and most compounds did not present significant cytotoxicity (CC50 MRC-5 = 32–64 μM). Despite the good balance between potency and selectivity, the antiparasitic activity of the series appeared to be driven by lipophilicity, making the progression of the series unfeasible due to poor ADME properties and potential promiscuity issues.Fil: Slafer, Brian W.. Universidade Estadual de Campinas; BrasilFil: Dessoy, Marco A.. Universidade Estadual de Campinas; BrasilFil: de Oliveira, Ramon G.. Universidade Estadual de Campinas; BrasilFil: Mollo, María Cruz. Universidade Estadual de Campinas; Brasil. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Lee, Eun. Universidade Estadual de Campinas; BrasilFil: Matheeussen, An. Universidade Estadual de Campinas; BrasilFil: Maes, Louis. Universidade Estadual de Campinas; BrasilFil: Caljon, Guy. Universiteit Antwerp; BélgicaFil: Ferreira, Leonardo L. G.. Universidade de Sao Paulo; BrasilFil: Krogh, Renata. Universidade de Sao Paulo; BrasilFil: Andricopulo, Adriano D.. Universidade de Sao Paulo; BrasilFil: Cruz, Luiza R.. No especifíca;Fil: Mowbray, Charles E.. No especifíca;Fil: Kratz, Jadel M.. No especifíca;Fil: Dias, Luiz C.. Universidade Estadual de Campinas; BrasilAmerican Chemical Society2024-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/236058Slafer, Brian W.; Dessoy, Marco A.; de Oliveira, Ramon G.; Mollo, María Cruz; Lee, Eun; et al.; Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives; American Chemical Society; ACS Omega; 5-2024; 1-112470-1343CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://pubs.acs.org/doi/10.1021/acsomega.4c01919info:eu-repo/semantics/altIdentifier/doi/10.1021/acsomega.4c01919info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:34:47Zoai:ri.conicet.gov.ar:11336/236058instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:34:47.671CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives |
title |
Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives |
spellingShingle |
Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives Slafer, Brian W. TRYPANOSOMA CRUZI DRUG DISCOVERY CHAGAS MULTIPARAMETRIC OPTIMIZATION |
title_short |
Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives |
title_full |
Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives |
title_fullStr |
Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives |
title_full_unstemmed |
Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives |
title_sort |
Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives |
dc.creator.none.fl_str_mv |
Slafer, Brian W. Dessoy, Marco A. de Oliveira, Ramon G. Mollo, María Cruz Lee, Eun Matheeussen, An Maes, Louis Caljon, Guy Ferreira, Leonardo L. G. Krogh, Renata Andricopulo, Adriano D. Cruz, Luiza R. Mowbray, Charles E. Kratz, Jadel M. Dias, Luiz C. |
author |
Slafer, Brian W. |
author_facet |
Slafer, Brian W. Dessoy, Marco A. de Oliveira, Ramon G. Mollo, María Cruz Lee, Eun Matheeussen, An Maes, Louis Caljon, Guy Ferreira, Leonardo L. G. Krogh, Renata Andricopulo, Adriano D. Cruz, Luiza R. Mowbray, Charles E. Kratz, Jadel M. Dias, Luiz C. |
author_role |
author |
author2 |
Dessoy, Marco A. de Oliveira, Ramon G. Mollo, María Cruz Lee, Eun Matheeussen, An Maes, Louis Caljon, Guy Ferreira, Leonardo L. G. Krogh, Renata Andricopulo, Adriano D. Cruz, Luiza R. Mowbray, Charles E. Kratz, Jadel M. Dias, Luiz C. |
author2_role |
author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
TRYPANOSOMA CRUZI DRUG DISCOVERY CHAGAS MULTIPARAMETRIC OPTIMIZATION |
topic |
TRYPANOSOMA CRUZI DRUG DISCOVERY CHAGAS MULTIPARAMETRIC OPTIMIZATION |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.4 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Chagas disease (CD) is a parasitic neglected tropical disease (NTD) caused by the protozoan Trypanosoma cruzi that affects 6 million people worldwide, often resulting in financial burden, morbidity, and mortality in endemic regions. Given a lack of highly efficient and safe treatments, new, affordable, and fit-for-purpose drugs for CD are urgently needed. In this work, we present a hit-to-lead campaign for novel cyanopyridine analogues as antichagasic agents. In a phenotypic screening against intracellular T. cruzi, hits 1 and 2 were identified and displayed promising potency combined with balanced physicochemical properties. As part of the Lead Optimization Latin America consortium, a set of 40 compounds was designed, synthesized, and tested against T. cruzi intracellular amastigotes and relevant human cell lines. The structural modifications were focused on three positions: cyanopyridine core, linker, and right-hand side. The ADME properties of selected compounds, lipophilicity, kinetic solubility, permeability, and liver microsomal stability, were evaluated. Compounds 1–9 displayed good potency (EC50 T. cruzi amastigote <1 μM), and most compounds did not present significant cytotoxicity (CC50 MRC-5 = 32–64 μM). Despite the good balance between potency and selectivity, the antiparasitic activity of the series appeared to be driven by lipophilicity, making the progression of the series unfeasible due to poor ADME properties and potential promiscuity issues. Fil: Slafer, Brian W.. Universidade Estadual de Campinas; Brasil Fil: Dessoy, Marco A.. Universidade Estadual de Campinas; Brasil Fil: de Oliveira, Ramon G.. Universidade Estadual de Campinas; Brasil Fil: Mollo, María Cruz. Universidade Estadual de Campinas; Brasil. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Lee, Eun. Universidade Estadual de Campinas; Brasil Fil: Matheeussen, An. Universidade Estadual de Campinas; Brasil Fil: Maes, Louis. Universidade Estadual de Campinas; Brasil Fil: Caljon, Guy. Universiteit Antwerp; Bélgica Fil: Ferreira, Leonardo L. G.. Universidade de Sao Paulo; Brasil Fil: Krogh, Renata. Universidade de Sao Paulo; Brasil Fil: Andricopulo, Adriano D.. Universidade de Sao Paulo; Brasil Fil: Cruz, Luiza R.. No especifíca; Fil: Mowbray, Charles E.. No especifíca; Fil: Kratz, Jadel M.. No especifíca; Fil: Dias, Luiz C.. Universidade Estadual de Campinas; Brasil |
description |
Chagas disease (CD) is a parasitic neglected tropical disease (NTD) caused by the protozoan Trypanosoma cruzi that affects 6 million people worldwide, often resulting in financial burden, morbidity, and mortality in endemic regions. Given a lack of highly efficient and safe treatments, new, affordable, and fit-for-purpose drugs for CD are urgently needed. In this work, we present a hit-to-lead campaign for novel cyanopyridine analogues as antichagasic agents. In a phenotypic screening against intracellular T. cruzi, hits 1 and 2 were identified and displayed promising potency combined with balanced physicochemical properties. As part of the Lead Optimization Latin America consortium, a set of 40 compounds was designed, synthesized, and tested against T. cruzi intracellular amastigotes and relevant human cell lines. The structural modifications were focused on three positions: cyanopyridine core, linker, and right-hand side. The ADME properties of selected compounds, lipophilicity, kinetic solubility, permeability, and liver microsomal stability, were evaluated. Compounds 1–9 displayed good potency (EC50 T. cruzi amastigote <1 μM), and most compounds did not present significant cytotoxicity (CC50 MRC-5 = 32–64 μM). Despite the good balance between potency and selectivity, the antiparasitic activity of the series appeared to be driven by lipophilicity, making the progression of the series unfeasible due to poor ADME properties and potential promiscuity issues. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-05 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/236058 Slafer, Brian W.; Dessoy, Marco A.; de Oliveira, Ramon G.; Mollo, María Cruz; Lee, Eun; et al.; Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives; American Chemical Society; ACS Omega; 5-2024; 1-11 2470-1343 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/236058 |
identifier_str_mv |
Slafer, Brian W.; Dessoy, Marco A.; de Oliveira, Ramon G.; Mollo, María Cruz; Lee, Eun; et al.; Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives; American Chemical Society; ACS Omega; 5-2024; 1-11 2470-1343 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://pubs.acs.org/doi/10.1021/acsomega.4c01919 info:eu-repo/semantics/altIdentifier/doi/10.1021/acsomega.4c01919 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
American Chemical Society |
publisher.none.fl_str_mv |
American Chemical Society |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614365149396992 |
score |
13.070432 |